genetech inc said still remain confid will abl work with food and drug adminstr obtain approv it tissu plasminogen activ activas for treat heart attack victim friday advisori committe fda recommend blood clot dissolv drug not approv until addit mortal data develop genetech said will addit data and believ much not all alreadi be develop reuter 